Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatorenal syndrome].

Péter Jarcuska1, Emil Fraenkel, János Fehér

  • 1I. interná klinika Lekárskej Fakulty Univerzity Pavla Jozefa Safárika a Fakultnej Nemocnice s Poliklinikou Kosice, Tr. SNP 1, Slovenská Republika. petjarc@yahoo.com

Orvosi Hetilap
|November 2, 2005
PubMed
Summary

Hepatorenal syndrome is kidney failure in patients with portal hypertension, often triggered by factors like infections or bleeding. While treatments can improve kidney function, they are notably expensive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of Alcohol-Associated Hepatitis: A Systematic Review of Population-Based Studies.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Impact of the removal of treatment barriers on the microelimination of chronic hepatitis C in Slovak prisons: experience from real-life settings.

Clinical and experimental hepatology·2026
Same author

Associations between DXA-derived parameters of body composition and bone mass density in patients with T2DM and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.

BMC endocrine disorders·2026
Same author

Metabolic syndrome and its individual components but not MASLD are associated with advanced fibrosis in primary biliary cholangitis.

Therapeutic advances in gastroenterology·2026
Same author

Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis.

World journal of hepatology·2026
Same author

Cohort Profile: The Youth Vascular Consortium.

Artery research·2026

Area of Science:

  • Nephrology
  • Gastroenterology
  • Hepatology

Context:

  • Hepatorenal syndrome (HRS) is a severe complication of advanced liver disease, characterized by functional renal failure.
  • It arises from splanchnic vasodilation secondary to portal hypertension, leading to reduced renal perfusion.
  • Key triggers include alcoholic hepatitis, inadequate diuretic use, infections, and gastrointestinal bleeding.

Purpose:

  • To elucidate the pathophysiological mechanisms underlying hepatorenal syndrome.
  • To outline current therapeutic strategies for managing HRS.
  • To assess the efficacy and cost-effectiveness of HRS treatments.

Summary:

  • HRS involves functional renal failure due to splanchnic vasodilation and decreased renal perfusion in portal hypertension.
  • Identified inductive factors include acute alcoholic hepatitis, improper diuretic therapy, infections, and upper GI bleeding.
  • Understanding the pathophysiology has enabled the development of effective therapeutic schemes.

Impact:

  • Recognition of HRS pathophysiology has led to improved therapeutic interventions.
  • Treatment can successfully restore renal function in a significant number of patients.
  • Current therapeutic regimens for HRS are associated with high costs.

Related Experiment Videos